Medication info
Viver tablet 200 mg (Acyclovir)

Viver tablet 200 mg (Acyclovir)

Prescription medicationTablet
Ingredient · strength
Acyclovir›200mg / 1 tablet
Manufacturer / importer
Hanmi Pharmaceutical Co., Ltd.
Appearance
White hexagonal tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 199902689 · Notified 1999.03.20 · Insurance code 643501110

Summary

Main use
Treatment and prevention of herpes simplex; treatment of herpes zoster; treatment of chickenpox in children
Who uses it
Adults · Children
Adult dosage
○ Adults 1. Treatment of herpes simplex virus infections 1) Administer acyclovir 200 mg per dose 5 times daily at 4-hour intervals for 5 days. Treatment may be extended for severe initial infections. 2) In patients with severe immunocompromise (e.g., after bone marrow transplantation) or gastrointestinal malabsorption, the dose per administration may be increased to 400 mg or the route of administration may be changed to intravenous injection. 3) It is best to start treatment as soon as possible after infection; for recurrent infections, treatment should preferably begin when prodromal symptoms or lesions first appear. 2. Prevention of herpes simplex infections in immunocompetent patients 1) Administer 200 mg per dose 4 times daily at approximately 6-hour intervals. Alternatively, 400 mg per dose may be administered twice daily at 12-hour intervals. 2) The dose may then be reduced to 200 mg per dose 2 ~ 3 times daily after confirming its efficacy. 3) To assess the natural course of the disease, long-term treatment should be periodically discontinued every 6 ~ 12 months for evaluation. 3. Prevention of herpes simplex infections in immunocompromised patients 1) Administer 200 mg per dose 4 times daily at approximately 6-hour intervals. 2) In patients with severe immunocompromise (e.g., after bone marrow transplantation) or gastrointestinal malabsorption, the dose per administration may be increased to 400 mg or the route of administration may be changed to intravenous injection. 3) Administer during the period of risk of infection. 4. Treatment of herpes zoster infections 1) Administer 800 mg per dose 5 times daily at approximately 4-hour intervals, excluding bedtime, for a total of 7 days. 2) Intravenous administration should be considered for patients with severe immunocompromise or gastrointestinal malabsorption. 3) It is best to start treatment as soon as possible after infection; the earlier treatment is started, the better the effect. ○ Patients with renal impairment Because patients with renal impairment are more likely to experience adverse neuropsychiatric reactions, use caution and extend the dosing interval or reduce the dose as appropriate. 1. Treatment of herpes simplex infections The oral dose is generally not higher than the amount that would accumulate following intravenous administration. However, for patients with severe renal impairment (creatinine clearance less than 10 mL per minute), this drug should preferably be administered at 200 mg every 12 hours. 2. Treatment of herpes zoster virus infections 1) For patients with creatinine clearance less than 10 mL per minute, the dose should preferably be reduced to 800 mg per dose twice daily, at approximately 12-hour intervals. 2) For patients with creatinine clearance of 10 ~ 25 mL per minute, the dose should preferably be reduced to 800 mg per dose 3 times daily, at approximately 8-hour intervals.
Children's dosage
○ Children 1. Treatment of herpes simplex infections and prevention of herpes simplex infections in immunocompromised patients Age 2 years and older: Same as adults. Under 2 years: Administer 1/2 of the adult dose. 2. Treatment of chickenpox in children 2 years and older Children 2 years and older: Administer 20 mg per kg of body weight (maximum 800 mg per dose) 4 times daily for 5 days. Treatment should be started as soon as possible after the chickenpox rash appears, preferably within 24 hours of rash onset.

Ingredients

Manufacturer
Hanmi Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment and prevention of herpes simplex; treatment of herpes zoster; treatment of chickenpox in children

  • Primary and recurrent genital herpes
  • herpes simplex virus infections of the skin and mucous membranes
  • shingles virus infections
  • acute pain
  • chickenpox
View approved original text

This medication is used for the treatment and prevention of herpes simplex virus infections of the skin and mucous membranes, including primary and recurrent genital herpes. It is also effective in treating shingles virus infections, particularly for alleviating acute pain. However, its efficacy for postherpetic neuralgia has not yet been clearly established. It is also used for the treatment of chickenpox in children over the age of 2, thus aiding in the treatment of viral infections across various age groups. Therefore, this medication is effectively utilized in the treatment and prevention of various viral infections.

Dosage and Administration

Adult dosage

○ Adults 1. Treatment of herpes simplex virus infections 1) Administer acyclovir 200 mg per dose 5 times daily at 4-hour intervals for 5 days. Treatment may be extended for severe initial infections. 2) In patients with severe immunocompromise (e.g., after bone marrow transplantation) or gastrointestinal malabsorption, the dose per administration may be increased to 400 mg or the route of administration may be changed to intravenous injection. 3) It is best to start treatment as soon as possible after infection; for recurrent infections, treatment should preferably begin when prodromal symptoms or lesions first appear. 2. Prevention of herpes simplex infections in immunocompetent patients 1) Administer 200 mg per dose 4 times daily at approximately 6-hour intervals. Alternatively, 400 mg per dose may be administered twice daily at 12-hour intervals. 2) The dose may then be reduced to 200 mg per dose 2 ~ 3 times daily after confirming its efficacy. 3) To assess the natural course of the disease, long-term treatment should be periodically discontinued every 6 ~ 12 months for evaluation. 3. Prevention of herpes simplex infections in immunocompromised patients 1) Administer 200 mg per dose 4 times daily at approximately 6-hour intervals. 2) In patients with severe immunocompromise (e.g., after bone marrow transplantation) or gastrointestinal malabsorption, the dose per administration may be increased to 400 mg or the route of administration may be changed to intravenous injection. 3) Administer during the period of risk of infection. 4. Treatment of herpes zoster infections 1) Administer 800 mg per dose 5 times daily at approximately 4-hour intervals, excluding bedtime, for a total of 7 days. 2) Intravenous administration should be considered for patients with severe immunocompromise or gastrointestinal malabsorption. 3) It is best to start treatment as soon as possible after infection; the earlier treatment is started, the better the effect. ○ Patients with renal impairment Because patients with renal impairment are more likely to experience adverse neuropsychiatric reactions, use caution and extend the dosing interval or reduce the dose as appropriate. 1. Treatment of herpes simplex infections The oral dose is generally not higher than the amount that would accumulate following intravenous administration. However, for patients with severe renal impairment (creatinine clearance less than 10 mL per minute), this drug should preferably be administered at 200 mg every 12 hours. 2. Treatment of herpes zoster virus infections 1) For patients with creatinine clearance less than 10 mL per minute, the dose should preferably be reduced to 800 mg per dose twice daily, at approximately 12-hour intervals. 2) For patients with creatinine clearance of 10 ~ 25 mL per minute, the dose should preferably be reduced to 800 mg per dose 3 times daily, at approximately 8-hour intervals.

Children's dosage

○ Children 1. Treatment of herpes simplex infections and prevention of herpes simplex infections in immunocompromised patients Age 2 years and older: Same as adults. Under 2 years: Administer 1/2 of the adult dose. 2. Treatment of chickenpox in children 2 years and older Children 2 years and older: Administer 20 mg per kg of body weight (maximum 800 mg per dose) 4 times daily for 5 days. Treatment should be started as soon as possible after the chickenpox rash appears, preferably within 24 hours of rash onset.

Precautions

This medication contains lactose; therefore, patients with a genetic disorder that impairs lactose digestion should not take it. Furthermore, patients who have had an allergic reaction to this medication or any of its ingredients should also avoid it. Patients with poor kidney function may experience mental and neurological side effects more easily when using this medication, thus caution is required. Patients with impaired liver function should use this medication carefully as it may worsen liver function. Infants and children should be cautious when using this medication, and elderly patients should also be careful due to higher risks of reducing kidney function and experiencing side effects. While taking this medication, there may be rare occurrences of serious allergic reactions such as anaphylaxis, so if symptoms such as decreased blood pressure, difficulty breathing, or chest tightness appear, the medication should be immediately stopped and medical personnel should be notified. Also, hypersensitivity reactions such as skin rashes, fever, vesicles, and hives may occur, and if such symptoms appear, the medication should be discontinued and appropriate treatment should be sought. Skin-related side effects may include hair loss, severe skin inflammation, and syndromes that cause serious damage to the skin and mucous membranes. Neurological symptoms may include disturbances of consciousness, loss of orientation, decreased concentration, aggression, confusion, hallucinations, convulsions, drowsiness, and insomnia, particularly affecting elderly patients or patients with reduced kidney function. With respect to kidney function issues, symptoms such as renal failure or blood or protein in the urine may manifest. Blood and lymphatic effects may include leukopenia, anemia, bleeding, and lymphadenopathy. Liver function abnormalities such as hepatitis, jaundice, and elevated liver enzymes have been reported, and gastrointestinal issues may include gastritis, vomiting, diarrhea, and abdominal pain, thus the medication should be stopped if symptoms occur. Systemically, symptoms such as fever, muscle weakness, fatigue, and headache may appear, and musculoskeletal symptoms may include joint pain and muscle pain. In the cardiovascular and circulatory systems, arrhythmias, chest pain, and changes in blood pressure may occur, while in the urinary system, difficulties in urination may rarely be seen. This medication should be taken for 5 days for the treatment of simplex herpes and chickenpox, and for 7 days for shingles. If symptoms do not improve after this time, alternative treatments should be considered. Treatment is most effective when started early; for shingles, treatment should be initiated within 5 days of skin symptoms appearing, and for chickenpox, within 3 days of onset. For patients with impaired immune function, intravenous administration should be considered, and adequate hydration is essential when using high doses to prevent dehydration and minimize kidney toxicity. For patients with recurrent genital herpes, the need for continued medication should be carefully reviewed after one year of treatment. While taking this medication, disturbances of consciousness may occur; therefore, caution should be exercised when driving or operating hazardous machinery, especially for patients with reduced kidney function. Interactions may occur when combined with other medications. For example, concomitant use with probenecid may increase the concentration of this medication in the body and slow its excretion. Co-administration with other drugs affecting kidney function may increase the risk of kidney damage. Concomitant use with cimetidine may decrease the excretion of this medication, increasing its serum concentration. Coadministration with theophylline may lead to symptoms of theophylline toxicity. When used with mycophenolate mofetil, concentrations of both drugs may increase. Women who are pregnant or may become pregnant should only use this medication when the benefits outweigh the risks, due to the potential risk of teratogenesis. This medication's ingredients may be excreted in breast milk, necessitating cessation of breastfeeding during treatment. Infants and children should only be given the minimum necessary dose, and special caution should be exercised when administering to neonates or low birth weight infants as safety has not been established. Elderly patients may be at increased risk of prolonged retention of the drug in the body due to reduced kidney function; therefore, dosage and dosing intervals should be adjusted, and adequate hydration should be ensured. In case of overdose, severe symptoms such as agitation, coma, convulsions, and drowsiness may appear, potentially leading to kidney damage. If overdose is suspected, the patient should be closely monitored and plasma drug concentrations measured, and if necessary, measures such as hemodialysis should be implemented to reduce drug levels.

Side effects

  • Anaphylactic shock
  • anaphylaxis-like reactions
  • hypotension
  • dyspnea
  • chest tightness
  • photosensitivity reactions
  • fixed drug eruptions
  • rash
  • fever
  • vesicles
Show 117 more
  • urticaria-like erythema
  • urticaria
  • alopecia
  • erythema multiforme
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • altered consciousness
  • disorientation
  • concentration difficulties
  • aggressive behavior
  • depersonalization
  • anxiety
  • ataxia
  • coma
  • confusion
  • delirium
  • stammering
  • encephalopathy
  • hallucinations
  • psychosis
  • seizures
  • drowsiness
  • tremors
  • agitation
  • forgetfulness
  • insomnia
  • anxiety
  • soliloquy
  • paresthesia
  • ataxia
  • inability to walk
  • involuntary movements
  • nystagmus
  • renal failure
  • crystalluria
  • increased BUN
  • elevated serum creatinine
  • hematuria
  • proteinuria
  • urinary red blood cell casts
  • pyuria
  • leukocytoclastic vasculitis
  • lymphadenopathy
  • hemorrhage
  • purpura
  • anemia
  • leukopenia
  • leukocytosis
  • eosinophilia
  • lymphocytosis
  • thrombocytosis
  • agranulocytosis
  • thrombocytopenia
  • basophilia
  • hepatitis
  • liver dysfunction
  • jaundice
  • abnormal liver function tests
  • hepatomegaly
  • gastritis
  • thirst
  • constipation
  • acute pancreatitis
  • diarrhea
  • loose stools
  • upper abdominal pain
  • stomach pain
  • abdominal pain
  • nausea
  • vomiting
  • dyspepsia
  • loss of appetite
  • glossitis
  • fever
  • peripheral edema
  • syncope
  • pallor
  • muscle weakness
  • lethargy
  • generalized fatigue
  • headache
  • arthralgia
  • myalgia
  • arrhythmia
  • chest pain
  • elevated blood pressure
  • decreased blood pressure
  • tachycardia
  • palpitations
  • urinary obstruction
  • dysuria
  • glycosuria
  • pneumonia
  • pharyngitis
  • pleural effusion
  • pain
  • hearing loss
  • conjunctivitis
  • visual disturbances
  • taste disorders
  • hair loss
  • sweating
  • hyponatremia
  • decreased serum protein
  • increased total cholesterol
  • increased triglycerides
  • elevated serum potassium
  • decreased serum albumin
  • anxiety
  • coma
  • seizures
  • drowsiness
  • confusion
  • hallucinations
  • agitation
  • epileptic seizures
  • comatose state

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be light-sensitive, so it should be stored in a container that blocks light. Additionally, it is recommended to store the medication at room temperature between 1 to 30 degrees Celsius. Proper storage will help maintain the drug's efficacy and safety.

Appearance and packaging

Appearance

White hexagonal tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.